These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 14746039)

  • 21. The combined impact of implementing HPV immunisation and primary HPV screening in New Zealand: Transitional and long-term benefits, costs and resource utilisation implications.
    Hall MT; Smith MA; Lew JB; O'Hallahan J; Fentiman G; Neal H; Sage M; Canfell K
    Gynecol Oncol; 2019 Mar; 152(3):472-479. PubMed ID: 30876491
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Promising strategies for cervical cancer screening in the post-human papillomavirus vaccination era.
    Tota J; Mahmud SM; Ferenczy A; Coutlée F; Franco EL
    Sex Health; 2010 Sep; 7(3):376-82. PubMed ID: 20719230
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A cost-utility analysis of cervical cancer screening and human papillomavirus vaccination in the Philippines.
    Guerrero AM; Genuino AJ; Santillan M; Praditsitthikorn N; Chantarastapornchit V; Teerawattananon Y; Alejandria M; Toral JA
    BMC Public Health; 2015 Jul; 15():730. PubMed ID: 26223975
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Early detection of cervical cancer with visual inspection methods: a summary of completed and on-going studies in India.
    Sankaranarayanan R; Nene BM; Dinshaw K; Rajkumar R; Shastri S; Wesley R; Basu P; Sharma R; Thara S; Budukh A; Parkin DM
    Salud Publica Mex; 2003; 45 Suppl 3():S399-407. PubMed ID: 14746033
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recommendations for cervical cancer prevention in Asia Pacific.
    Garland SM; Cuzick J; Domingo EJ; Goldie SJ; Kim YT; Konno R; Parkin DM; Qiao YL; Sankaranarayanan R; Stern PL; Tay SK; Bosch FX
    Vaccine; 2008 Aug; 26 Suppl 12():M89-98. PubMed ID: 18945418
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Can human papillomavirus testing and vaccination prevent cervical cancer?].
    Lie AK; Bjørge T; Helland A; Hagen B; Skjeldestad FE; Hagmar B; Thoresen S
    Tidsskr Nor Laegeforen; 2001 Oct; 121(25):2947-51. PubMed ID: 11715778
    [TBL] [Abstract][Full Text] [Related]  

  • 27. VIA/VILI is more suitable for cervical cancer prevention in Chinese poverty-stricken region: a health economic evaluation.
    Xie Y; Tan X; Shao H; Liu Q; Tou J; Zhang Y; Luo Q; Xiang Q
    BMC Public Health; 2017 Jan; 17(1):118. PubMed ID: 28122530
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer.
    Arbyn M; Ronco G; Anttila A; Meijer CJ; Poljak M; Ogilvie G; Koliopoulos G; Naucler P; Sankaranarayanan R; Peto J
    Vaccine; 2012 Nov; 30 Suppl 5():F88-99. PubMed ID: 23199969
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Infrastructure requirements for human papillomavirus vaccination and cervical cancer screening in sub-Saharan Africa.
    Sankaranarayanan R; Anorlu R; Sangwa-Lugoma G; Denny LA
    Vaccine; 2013 Dec; 31 Suppl 5():F47-52. PubMed ID: 24331747
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Implementation of National Cervical Cancer Screening Program in France].
    Woronoff AS; Molinié F; Trétarre B
    Bull Cancer; 2019 Mar; 106(3):253-261. PubMed ID: 30635113
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Primary HPV testing versus cytology-based cervical screening in women in Australia vaccinated for HPV and unvaccinated: effectiveness and economic assessment for the National Cervical Screening Program.
    Lew JB; Simms KT; Smith MA; Hall M; Kang YJ; Xu XM; Caruana M; Velentzis LS; Bessell T; Saville M; Hammond I; Canfell K
    Lancet Public Health; 2017 Feb; 2(2):e96-e107. PubMed ID: 29253402
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Study on the value assessment of various screening programs regarding cervical cancer screening strategy in the rural areas of China].
    Li LY; Qiao ZQ; Zhang MF; Yang JP; Bao YP; An YT; Lei J; Xiong NH; Yu XH; Zhang X; Pan QJ; Qiao YL
    Zhonghua Liu Xing Bing Xue Za Zhi; 2007 Oct; 28(10):964-7. PubMed ID: 18399140
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vaccines against human papillomavirus and perspectives for the prevention and control of cervical cancer.
    García-Carrancá A
    Salud Publica Mex; 2003; 45 Suppl 3():S437-42. PubMed ID: 14746037
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of HPV test versus conventional and automation-assisted Pap screening as potential screening tools for preventing cervical cancer.
    Nieminen P; Vuorma S; Viikki M; Hakama M; Anttila A
    BJOG; 2004 Aug; 111(8):842-8. PubMed ID: 15270934
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epidemiology of human papillomavirus infections: new options for cervical cancer prevention.
    Bosch FX
    Salud Publica Mex; 2003; 45 Suppl 3():S326-39. PubMed ID: 14746025
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Making the case for cervical cancer prevention: what about equity?
    Tsu VD; Levin CE
    Reprod Health Matters; 2008 Nov; 16(32):104-12. PubMed ID: 19027628
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Prevention of cervical cancer: screening, progress and perspectives].
    Monsonego J
    Presse Med; 2007 Jan; 36(1 Pt 2):92-111. PubMed ID: 17296477
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human papillomavirus screening and cervical cancer prevention.
    Sasieni PD
    J Am Med Womens Assoc (1972); 2000; 55(4):216-9. PubMed ID: 10935355
    [TBL] [Abstract][Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.